Adaptive Biotechnologies (ADPT) Interest & Investment Income (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Interest & Investment Income data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Interest & Investment Income fell 22.36% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 31.91% YoY) and the FY2025 annual result came in at $9.4 million, down 35.02% from the prior year.
• Interest & Investment Income eased to $2.1 million in Q1 2026 per ADPT's latest filing, from $2.1 million in the prior quarter.
• The five-year high for Interest & Investment Income was $4.6 million in Q4 2023, with the low at $271000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $2.7 million, with a median of $2.7 million recorded in 2025.
• Year-over-year, Interest & Investment Income sank 57.52% in 2022 and jumped 1015.87% in 2023.
• Adaptive Biotechnologies' Interest & Investment Income stood at $2.6 million in 2022, then surged by 77.29% to $4.6 million in 2023, then tumbled by 33.41% to $3.1 million in 2024, then plunged by 30.08% to $2.1 million in 2025, then decreased by 3.17% to $2.1 million in 2026.
• Business Quant data shows ADPT's Interest & Investment Income at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.2 million in Q3 2025.